Nicolas André Selected Research

Nicolas André Research Topics

Disease

61	Neoplasms (Cancer) 10/2022 - 05/2002
6	Medulloblastoma 08/2022 - 01/2018
6	Glioma (Gliomas) 01/2022 - 08/2015
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2021 - 09/2010
6	Neoplasm Metastasis (Metastasis) 01/2021 - 09/2007
5	Neuroblastoma 01/2021 - 12/2002
5	Rhabdomyosarcoma 10/2020 - 10/2012
5	Neutropenia 07/2020 - 11/2006
4	Breast Neoplasms (Breast Cancer) 01/2017 - 10/2011
3	Mesothelioma 11/2020 - 11/2006
3	Cardiotoxicity 06/2020 - 12/2016
3	Febrile Neutropenia 10/2016 - 03/2007
3	Hemangiosarcoma (Angiosarcoma) 04/2016 - 01/2014
2	COVID-19 12/2020 - 11/2020
2	Hematologic Neoplasms (Hematological Malignancy) 11/2020 - 10/2016
2	Malignant Mesothelioma 11/2020 - 04/2016
2	Thrombocytopenia (Thrombopenia) 07/2020 - 11/2006
2	Brain Neoplasms (Brain Tumor) 01/2018 - 07/2012
2	Triple Negative Breast Neoplasms 01/2017 - 10/2011
2	Lung Neoplasms (Lung Cancer) 01/2017 - 09/2014
2	Body Weight (Weight, Body) 10/2016 - 03/2007
2	Burkitt Lymphoma (Burkitt's Lymphoma) 10/2014 - 01/2011
2	Prostatic Neoplasms (Prostate Cancer) 01/2014 - 02/2009
2	Lymphoma (Lymphomas) 03/2012 - 05/2002
2	Ewing Sarcoma (Sarcoma, Ewing) 08/2009 - 01/2009
1	Brain Stem Neoplasms (Brain Stem Tumor) 01/2021
1	Diffuse Intrinsic Pontine Glioma 01/2021
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Hypoxia (Hypoxemia) 10/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2020
1	Hamartoma 01/2020
1	Ependymoma 01/2018
1	Neurofibroma 01/2018
1	Primitive Neuroectodermal Tumors (PNET) 01/2018
1	Typical Teratoid Rhabdoid Tumor 01/2017

Drug/Important Bio-Agent (IBA)

13	Pharmaceutical PreparationsIBA 08/2022 - 03/2010
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 07/2008
6	Vinorelbine (Navelbine)FDA LinkGeneric 01/2022 - 10/2012
6	Bevacizumab (Avastin)FDA Link 01/2021 - 12/2010
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2011
4	Vinblastine (Vinblastine Sulfate)FDA Link 01/2021 - 02/2011
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 07/2012
4	Gemcitabine FDA Link 01/2017 - 05/2010
3	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2020 - 12/2016
3	Propranolol (Inderal)FDA LinkGeneric 01/2017 - 10/2011
3	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2014 - 08/2009
3	Antineoplastic Agents (Antineoplastics)IBA 11/2013 - 09/2007
3	Paclitaxel (Taxol)FDA LinkGeneric 10/2011 - 05/2002
2	Cell-Free Nucleic AcidsIBA 10/2022 - 01/2022
2	Adrenergic Receptors (Adrenergic Receptor)IBA 08/2022 - 04/2016
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2017
2	Sirolimus (Rapamycin)FDA Link 11/2021 - 10/2020
2	Pemetrexed (MTA)FDA Link 11/2020 - 11/2006
2	CateninsIBA 11/2020 - 08/2012
2	Vincristine (Oncovin)FDA LinkGeneric 07/2020 - 01/2011
2	AnthracyclinesIBA 06/2020 - 08/2015
2	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 07/2008
2	Methotrexate (Mexate)FDA LinkGeneric 04/2016 - 01/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2015 - 07/2012
2	Celecoxib (Celebrex)FDA Link 05/2013 - 07/2008
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2009 - 03/2007
2	Filgrastim (Neupogen)FDA Link 01/2009 - 03/2007
2	pegfilgrastim (Neulasta)FDA Link 01/2009 - 03/2007
1	Superoxides (Superoxide)IBA 08/2022
1	beta Adrenergic ReceptorsIBA 08/2022
1	Temozolomide (Temodar)FDA LinkGeneric 11/2021
1	vistusertibIBA 11/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2021
1	Topotecan (Hycamtin)FDA LinkGeneric 11/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2021
1	NivolumabIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	BNT162 VaccineIBA 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	dipinacoline glutamateIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	TIC10 compoundIBA 01/2021
1	AsbestosIBA 11/2020
1	Dactinomycin (Actinomycin)FDA LinkGeneric 07/2020
1	Ifosfamide FDA LinkGeneric 07/2020
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2020
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 12/2019
1	Biological FactorsIBA 01/2018
1	MB 5IBA 01/2018
1	MEK inhibitor IIBA 01/2018
1	Metformin (Glucophage)FDA LinkGeneric 01/2017

Therapy/Procedure

30	Drug Therapy (Chemotherapy) 05/2021 - 11/2006
21	Therapeutics 10/2022 - 09/2007
6	Radiotherapy 08/2022 - 05/2013
2	Terminal Care (Care, Terminal) 01/2021 - 01/2019
2	Investigational Therapies (Experimental Therapy) 01/2021 - 12/2020
2	Immunotherapy 01/2016 - 12/2015
1	Salvage Therapy 01/2022
1	Precision Medicine 01/2022
1	Hematopoietic Stem Cell Transplantation 11/2020
1	Cytoreduction Surgical Procedures 11/2020
1	Craniospinal Irradiation 01/2018
1	Palliative Care (Palliative Therapy) 01/2017